menu ☰
menu ˟

LVAD now approved as destination therapy

19 Oct 2018
Abbott announced that its newest-generation left ventricular assist device has been approved by the FDA for implantation in patients with advanced HF ineligible for a heart transplant.The LVAD (HeartMate 3, Abbott), which includes a continuous centri...

Click here to view the full article which appeared in

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.